Hair grows in cycles consisting of a growth phase (anagen), a transitional phase, and a resting phase (telogen)
While Tirzepatide may represent a promising development in diabetes management and weight loss, its crucial to remember that it may not be suitable for everyone
Loomba R et al., SYNERGY-NASH, NEJM 2024 (NEJMoa2401943, PMID 38856224) : tirzepatide and MASH, resolution in 62% at the 15 mg level
However, certain symptoms warrant a call to your healthcare provider: Nausea severe enough to prevent eating or drinking for more than 24 hours Persistent vomiting, especially if it continues beyond 24 hours Signs of dehydration (dark urine, dizziness when standing, dry mouth) Severe abdominal pain that does not resolve Diarrhea that continues for more than three days In rare cases, your prescriber may temporarily reduce the tirzepatide dose or pause the dose escalation until GI symptoms resolve
It does maintain a Willow Facebook Community for patients to connect with each other
